Status:
COMPLETED
Follow Up Study for Treatment of Parkinson's Disease With Subthalamic Deep Brain Stimulation
Lead Sponsor:
Ruijin Hospital
Conditions:
Parkinson Disease
Eligibility:
All Genders
18-75 years
Brief Summary
This study aims to evaluate the long term effect of deep brain stimulation in the the subthalamic nucleus (STN) in patients with Parkinson's disease.
Eligibility Criteria
Inclusion
- Idiopathic Parkinson's disease
- Disease duration longer than 15 years
- Had STN deep brain stimulation implant more than 10 years
- Available and willing to be followed-up according to study protocol
Exclusion
- Patients with serious diseases such as tumor, sever liver or kidney dysfunction were not selected in the clinical trials
- Epilepsy
- Pregnant female
- History of severe neuropsychiatric disease
- Patients are taking part in other clinical trials in recent several months
Key Trial Info
Start Date :
July 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03230331
Start Date
July 24 2017
End Date
May 1 2019
Last Update
March 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China